澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TELIX PHARMACEUTICALS LTD

9.745

-0.115-1.17%

成交量：22.45萬

成交額：220.84萬

市值：33.01億

市盈率：162.10

高：9.950

開：9.880

低：9.745

收：9.860

52周最高：31.970

52周最低：9.590

股本：3.39億

流通股本：2.75億

量比：1.62

換手率：0.08%

股息：- -

股息率：- -

每股收益(TTM):0.060

每股收益(LYR):0.204

淨資產收益率：3.14%

總資產收益率：2.08%

市淨率：5.55

市盈率(LYR):47.80

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Telix實現2025財年營收8.04億美元（12億澳元）目標，Gozellix上市加速增長

BUZZ-澳大利亞泰利克斯製藥公司因中國接受新藥申請而上漲

精準醫療投資組合更新：Illuccix中國三期研究及Tlx101-Cdx和Tlx250-Cdx FDA重新提交

Thor Medical與Telix Pharmaceuticals簽署戰略供應協議，提供銩228

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TLX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":9.745,"timestamp":1770678972644,"preClose":9.86,"halted":0,"volume":224491,"delay":0,"changeRate":-0.011663286004056818,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.060115606936416176,"marketStatus":"交易中","change":-0.115,"latestTime":"02-10 10:16:14 AEDT","open":9.88,"high":9.95,"low":9.745,"amount":2208443,"amplitude":0.020791,"askPrice":9.75,"askSize":5228,"bidPrice":9.74,"bidSize":6511,"shortable":3,"etf":0,"ttmEps":0.060115606936416176,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":9.86,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":1.621486,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.08%","roe":"3.14%","lyrEps":0.203863,"volumeRatio":1.621486,"shares":338721355,"dividePrice":0,"high":9.95,"amplitude":0.020791,"preClose":9.86,"low":9.745,"week52Low":9.59,"pbRate":"5.55","psRate":"3.52","week52High":31.97,"institutionHeld":0,"latestPrice":9.745,"committee":0.109294,"eps":0.060115606936416176,"divideRate":0,"volume":224491,"delay":0,"ttmEps":0.060115606936416176,"open":9.88,"prevYearClose":11.2,"prevWeekClose":9.85,"prevMonthClose":10.55,"prevQuarterClose":11.2,"fiveDayClose":10.21,"twentyDayClose":11.2,"sixtyDayClose":14.93,"earningDate":1771430400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null},{"date":"2024-08-22","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724284800000,"name":null,"time":"","dateTimestamp":1724248800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1167408007","title":"Telix實現2025財年營收8.04億美元（12億澳元）目標，Gozellix上市加速增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1167408007","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167408007?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 20:07","pubTimestamp":1768910869,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals Ltd宣布达成2025财年业绩指引，实现营收8.04亿美元。公司同时推出新型放射性药物Gozellix，标志着其肿瘤靶向治疗产品线的重大拓展。这一突破性进展不仅巩固了Telix在核医学领域的领先地位，更为全球癌症患者提供了更精准的治疗选择。随着Gozellix的正式商业化，Telix将同步启动全球市场推广计划。Telix首席执行官表示，此次双里程碑的达成得益于公司持续的技术创新与全球化战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2604055151","title":"BUZZ-澳大利亞泰利克斯製藥公司因中國接受新藥申請而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2604055151","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604055151?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 08:39","pubTimestamp":1768869597,"startTime":"0","endTime":"0","summary":"1月20日 - ** 澳大利亚泰利克斯制药公司TLX.AX股价上涨6.3%至11.99澳元，创下近两个月来最大盘中涨幅。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4S3YL01L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNLX","BK1191","BK4157","BK7067","00512","TLX.AU"],"gpt_icon":0},{"id":"1170607192","title":"精準醫療投資組合更新：Illuccix中國三期研究及Tlx101-Cdx和Tlx250-Cdx FDA重新提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1170607192","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170607192?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 05:40","pubTimestamp":1766353209,"startTime":"0","endTime":"0","summary":"精准医疗投资组合更新：Illuccix中国三期研究及Tlx101-Cdx和Tlx250-Cdx FDA重新提交","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"1108683421","title":"Thor Medical與Telix Pharmaceuticals簽署戰略供應協議，提供銩228","url":"https://stock-news.laohu8.com/highlight/detail?id=1108683421","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108683421?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 00:51","pubTimestamp":1763571104,"startTime":"0","endTime":"0","summary":"11月6日 - Thor Medical ASA宣布与Telix Pharmaceuticals达成战略供应协议，将在未来五年内向Telix供应铥228。从2026年第三季度起，铥228将从AlphaOne基地开始供给。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TLX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}